Medindia
Medindia LOGIN REGISTER
Advertisement

BioInformatics, LLC Studies Effective Strategies for Scientific Publishing in a Web 2.0 World

Tuesday, December 2, 2008 General News
Advertisement
ARLINGTON, Va., Dec. 1 BioInformatics, LLC(http://www.gene2drug.com) -- the leading market research and consulting firmserving the life science industry -- announces the publication of its latestreport, "The Brave New World of Scientific Publishing." Going beyond theoriginal social media study published jointly in 2007 by BioInformatics andPJA -- an award-winning business-to-business advertising and marketing agency-- this report explores the impact of Web 2.0 and Social Media applications ontraditional publishing methodologies, and provides insight on how to bestembrace this new industry standard to maintain a leadership role within thescientific community.
Advertisement

An in-depth analysis of the opinions of over 1,500 life scientists, thisreport uncovers key findings about how scientists rely on the Web forresearch, collaboration and networking. Discussion boards, blogs, wikis videoand podcasts -- scientists are learning how to employ Web 2.0 and social mediatools to good effect. Additionally, the report indicates that reliance ontraditional media as an information source is waning, while onlinecollaborative tools are becoming increasingly valuable to today's researcher.
Advertisement

A North American Lab Director had this to say: "The traditional peerreview system is too slow, outdated, becoming obsolete... articles should bepublished right away on the net, linked by aggregator sites so otherscientists can review and post comments online. This would open peer reviewto a much wider audience (hundreds can comment instead of 3-4) and shouldimprove the quality of science."

Findings reveal that traditional publishing models, while still viable, nolonger stand alone as a way to thrive in a community of scientists who wantmore speed, more control and easier access to information than ever before.Plus, scientists want to be heard. Publishers that understand this -- andadapt -- are already taking the lead.

"Our assessment is that publishers are well-placed to deliver social toolsin a secure and trusted environment, but they also need to innovate tools thatare more relevant, focused and easy to use," observes noted science writerRichard Grant, who served as a lead consultant on the report.

The time for "wait and see" is past; The Brave New World of ScientificPublishing provides the advantage required to anticipate and deliver on theneeds of the modern scientist. "An organization must leverage its existingreputation to join -- and influence -- the online dialogue," notes Dr. TamaraZemlo, Director of Syndicated Research and Analysis for BioInformatics, LLC.This report is a must-read for any company looking to remain competitivewithin the rapidly evolving scientific community.

The Brave New World of Scientific Publishing is based on 1,557 responsesto a 37 question online survey fielded to The Science Advisory Board in May2008. BioInformatics LLC sponsors this global online community of more than40,000 scientists, physicians and healthcare professionals.

ABOUT BIOINFORMATICS, LLC

BioInformatics, LLC is the premier research and advisory firm serving thelife science industry. By leveraging our professional social network of morethan 40,000 biomedical researchers, we have supported more than 300 companiesand provided insights that lead to better business decisions. Our assignmentsinclude assessing the size and attractiveness of markets, optimizing productconfigurations and pricing, validating corporate acquisitions, measuringcustomer loyalty, and evaluating brand strength and positioning.To purchase this report or for additional information, please contact: Mary Follin Director of Communications BioInformatics, LLC 2111 Wilson Blvd., Suite 250 Arlington, VA 22201 703.778.3080 x13 (phone) [email protected] http://www.gene2drug.com/

SOURCE BioInformatics, LLC
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close